| 	
		 | 
    
		  my account
			
	  log out
		
 | 
  
Anti-GRM2 VHH | 
| Create: 01/11/2017 | 
| Expired Date: | 01/02/2018 | 
| Category: | Drugs&Pharmaceutical [Health&Medical&Pharmaceutical] | 
| Message: | The anti-metabotropic glutamate receptor subtype 2 (mGluR2) conformational single domain antibody target mGluR2 which contribute to the fine-tuning of synaptic efficacy. The llama-derived anti-mGluR2 single domain antibody act as a positive allosteric modulator and are able to stabilized the active state of mGluR2. Therefore, the anti-mGluR2 single domain antibody can be useful in the treatment of schizophrenia, epilepsy, addiction/drug dependence, Parkinson's disease, pain, sleep disorders and Huntington's disease. | 
| City: | Shirley[US] 
 | 
| Location: | 
 | 
| Feb 01 2023 | VBS++ (with Ca and Mg) Buffer | 268 | |
| Feb 01 2023 | GVBE Buffer | 276 | |
| Feb 01 2023 | GVB++ (with Ca and Mg) Buffer | 276 | |
| Feb 01 2023 | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | 270 | |
| Aug 30 2019 | Anti-HSV-2 gH Antibody | 461 | |
| Aug 30 2019 | Anti-L. major LPG Antibody | 543 | |
| Aug 30 2019 | Anti-DENV-1 Antibody | 451 | |
| Aug 30 2019 | Anti-BPV-1 L1 Antibody | 465 | |
| Aug 30 2019 | Anti-H3N2 HA Antibody | 453 | |
| Aug 30 2019 | Anti-EIAV env Antibody | 473 | 
| Copyright © toextrade Inc. All rights reserved. Contact us |